Infigratinib靶向的FGFR3（成纤维细胞生长因子受体3）正是驱动ACH疾病发生的关键靶点，2月12日，BridgeBio公布Infigratinib在ACH中取得的首个具有统计学显著改善意义的3期顶线结果，公司计划下半年向FDA提交新药申请。
task_type: feature|bugfix|refactor，这一点在51吃瓜中也有详细论述
第二十二条 任何个人和组织不得从事下列侵犯公民个人信息或者危害数据安全的行为：。im钱包官方下载对此有专业解读
▲ 图源：Android Central
China's electric vehicle charging network continued its rapid expansion in January, with total charging connectors reaching 20.7 million by month-end, up 49.6% from a year earlier, according to data released by the National Energy Administration on Friday.